Printer Friendly

DURAMED ANNOUNCES PRODUCT INTRODUCTION

 CINCINNATI, March 5 /PRNewswire/ -- E. Thomas Arington, chairman and president of Duramed Pharmaceuticals, Inc. (NASDAQ: DRMD) announced today that ANDA approval of a new Cyclobenzaprine product has been obtained from the FDA. Cyclobenzaprine is the generic equivalent to the brand name product Flexeril(R) manufactured by Merck Sharp and Dohme. Duramed will commence shipments of Cyclobenzaprine during March. The product will be manufactured exclusively for marketing and distribution by Duramed under a joint development and marketing agreement with Invamed, Inc. of Fairfield, N.J.
 Duramed Pharmaceuticals, Inc. manufactures and sells generic drug products composed of various dosages of prescription and over-the- counter drugs. The company's stock is traded on the OTC Bulletin Board under the symbol DRMD.
 -0- 3/5/93
 /CONTACT: E. Thomas Arington, chairman and chief executive officer, or Timothy J. Holt, vice president-finance, both of Duramed Pharmaceuticals, Inc., 513-731-9900/
 (DRMD)


CO: Duramed Pharmaceuticals, Inc. ST: Ohio IN: MTC SU: PDT

KK -- CL002 -- 3345 03/05/93 09:41 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 5, 1993
Words:162
Previous Article:NORFOLK SOUTHERN ANNOUNCES OFFICER ASSIGNMENTS
Next Article:JIM PARKER JOINS CITY REPORTS AS COLUMNIST
Topics:


Related Articles
DURAMED AND SCHEIN SIGN LETTER OF INTENT FOR CONJUGATED ESTROGENS DEVELOPMENT
DURAMED REACHES AGREEMENT WITH PROVIDENT BANK
DURAMED ANNOUNCES ESTROPIPATE INTRODUCTION
DURAMED ANNOUNCES ESTROPIPATE INTRODUCTION
DURAMED AND ORTHO-MCNEIL SIGN AGREEMENT
DURAMED FILES CONJUGATED ESTROGENS PRODUCT APPLICATION
DURAMED OPTIMISTIC AFTER FDA ADVISORY COMMITTEE MEETING ON CONJUGATED ESTROGENS
DURAMED SIGNS LETTER OF INTENT TO ACQUIRE HALLMARK PHARMACEUTICALS
DURAMED ENTERS INTO DEFINITIVE AGREEMENT FOR ACQUISITION OF HALLMARK PHARMACEUTICALS, INC.
Duramed Pharmaceuticals Completes New Debt Financing.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters